ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intradermal Needle-free Vaccination System Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-2J19227
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Intradermal Needle free Vaccination System Market Research Report 2025
BUY CHAPTERS

Global Intradermal Needle-free Vaccination System Market Research Report 2025

Code: QYRE-Auto-2J19227
Report
March 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Henke Sass Wolf
Hipra
Merck
Pulse NeedleFree Systems
AcuShot™Inc.
NuGen Medical
Shine Moon
Jiangsu Leju Pharmaceutical Technology

Intradermal Needle-free Vaccination System Market Size

The global market for Intradermal Needle-free Vaccination System was valued at US$ 74.7 million in the year 2024 and is projected to reach a revised size of US$ 125 million by 2031, growing at a CAGR of 7.6% during the forecast period.

Intradermal Needle-free Vaccination System Market

Intradermal Needle-free Vaccination System Market

The Intradermal Needle-free Vaccination System is a medical device designed to administer vaccines without the use of traditional needles. It uses a high-pressure jet to deliver the vaccine directly into the skin (the intradermal layer) rather than through muscle or fat. This system is typically more comfortable for patients, reduces the risk of needle-related injuries, and can improve vaccination efficiency by targeting the skin's immune cells. The needle-free technology is often used for both human and animal vaccinations, offering a less invasive and potentially more cost-effective alternative to conventional needle-based methods.
North American market for Intradermal Needle-free Vaccination System is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Intradermal Needle-free Vaccination System is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Intradermal Needle-free Vaccination System include Henke Sass Wolf, HIPRA, Merck, Pulse NeedleFree Systems, AcuShot, NuGen Medical, Shine Moon, Jiangsu Leju Pharmaceutical Technology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intradermal Needle-free Vaccination System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intradermal Needle-free Vaccination System.
The Intradermal Needle-free Vaccination System market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intradermal Needle-free Vaccination System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intradermal Needle-free Vaccination System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Intradermal Needle-free Vaccination System Market Report

Report Metric Details
Report Name Intradermal Needle-free Vaccination System Market
Accounted market size in year US$ 74.7 million
Forecasted market size in 2031 US$ 125 million
CAGR 7.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Pen-type
  • Gun-type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Henke Sass Wolf, HIPRA, Merck, Pulse NeedleFree Systems, AcuShot, NuGen Medical, Shine Moon, Jiangsu Leju Pharmaceutical Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Intradermal Needle-free Vaccination System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Intradermal Needle-free Vaccination System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Intradermal Needle-free Vaccination System Market growing?

Ans: The Intradermal Needle-free Vaccination System Market witnessing a CAGR of 7.6% during the forecast period 2025-2031.

What is the Intradermal Needle-free Vaccination System Market size in 2031?

Ans: The Intradermal Needle-free Vaccination System Market size in 2031 will be US$ 125 million.

Who are the main players in the Intradermal Needle-free Vaccination System Market report?

Ans: The main players in the Intradermal Needle-free Vaccination System Market are Henke Sass Wolf, HIPRA, Merck, Pulse NeedleFree Systems, AcuShot, NuGen Medical, Shine Moon, Jiangsu Leju Pharmaceutical Technology

What are the Application segmentation covered in the Intradermal Needle-free Vaccination System Market report?

Ans: The Applications covered in the Intradermal Needle-free Vaccination System Market report are Pets and Small Animals, Large Animals

What are the Type segmentation covered in the Intradermal Needle-free Vaccination System Market report?

Ans: The Types covered in the Intradermal Needle-free Vaccination System Market report are Pen-type, Gun-type

Recommended Reports

Needle-free Injection

Microneedle Systems

Injection/Vaccine Delivery

1 Intradermal Needle-free Vaccination System Market Overview
1.1 Product Definition
1.2 Intradermal Needle-free Vaccination System by Type
1.2.1 Global Intradermal Needle-free Vaccination System Market Value Comparison by Type (2024 VS 2031)
1.2.2 Pen-type
1.2.3 Gun-type
1.3 Intradermal Needle-free Vaccination System by Application
1.3.1 Global Intradermal Needle-free Vaccination System Market Value by Application (2024 VS 2031)
1.3.2 Pets and Small Animals
1.3.3 Large Animals
1.4 Global Intradermal Needle-free Vaccination System Market Size Estimates and Forecasts
1.4.1 Global Intradermal Needle-free Vaccination System Revenue 2020-2031
1.4.2 Global Intradermal Needle-free Vaccination System Sales 2020-2031
1.4.3 Global Intradermal Needle-free Vaccination System Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Intradermal Needle-free Vaccination System Market Competition by Manufacturers
2.1 Global Intradermal Needle-free Vaccination System Sales Market Share by Manufacturers (2020-2025)
2.2 Global Intradermal Needle-free Vaccination System Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Intradermal Needle-free Vaccination System Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Intradermal Needle-free Vaccination System, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intradermal Needle-free Vaccination System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intradermal Needle-free Vaccination System, Product Type & Application
2.7 Global Key Manufacturers of Intradermal Needle-free Vaccination System, Date of Enter into This Industry
2.8 Global Intradermal Needle-free Vaccination System Market Competitive Situation and Trends
2.8.1 Global Intradermal Needle-free Vaccination System Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Intradermal Needle-free Vaccination System Players Market Share by Revenue
2.8.3 Global Intradermal Needle-free Vaccination System Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intradermal Needle-free Vaccination System Market Scenario by Region
3.1 Global Intradermal Needle-free Vaccination System Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Intradermal Needle-free Vaccination System Sales by Region: 2020-2031
3.2.1 Global Intradermal Needle-free Vaccination System Sales by Region: 2020-2025
3.2.2 Global Intradermal Needle-free Vaccination System Sales by Region: 2026-2031
3.3 Global Intradermal Needle-free Vaccination System Revenue by Region: 2020-2031
3.3.1 Global Intradermal Needle-free Vaccination System Revenue by Region: 2020-2025
3.3.2 Global Intradermal Needle-free Vaccination System Revenue by Region: 2026-2031
3.4 North America Intradermal Needle-free Vaccination System Market Facts & Figures by Country
3.4.1 North America Intradermal Needle-free Vaccination System Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Intradermal Needle-free Vaccination System Sales by Country (2020-2031)
3.4.3 North America Intradermal Needle-free Vaccination System Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intradermal Needle-free Vaccination System Market Facts & Figures by Country
3.5.1 Europe Intradermal Needle-free Vaccination System Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Intradermal Needle-free Vaccination System Sales by Country (2020-2031)
3.5.3 Europe Intradermal Needle-free Vaccination System Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intradermal Needle-free Vaccination System Market Facts & Figures by Region
3.6.1 Asia Pacific Intradermal Needle-free Vaccination System Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Intradermal Needle-free Vaccination System Sales by Region (2020-2031)
3.6.3 Asia Pacific Intradermal Needle-free Vaccination System Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Intradermal Needle-free Vaccination System Market Facts & Figures by Country
3.7.1 Latin America Intradermal Needle-free Vaccination System Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Intradermal Needle-free Vaccination System Sales by Country (2020-2031)
3.7.3 Latin America Intradermal Needle-free Vaccination System Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Intradermal Needle-free Vaccination System Market Facts & Figures by Country
3.8.1 Middle East and Africa Intradermal Needle-free Vaccination System Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Intradermal Needle-free Vaccination System Sales by Country (2020-2031)
3.8.3 Middle East and Africa Intradermal Needle-free Vaccination System Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intradermal Needle-free Vaccination System Sales by Type (2020-2031)
4.1.1 Global Intradermal Needle-free Vaccination System Sales by Type (2020-2025)
4.1.2 Global Intradermal Needle-free Vaccination System Sales by Type (2026-2031)
4.1.3 Global Intradermal Needle-free Vaccination System Sales Market Share by Type (2020-2031)
4.2 Global Intradermal Needle-free Vaccination System Revenue by Type (2020-2031)
4.2.1 Global Intradermal Needle-free Vaccination System Revenue by Type (2020-2025)
4.2.2 Global Intradermal Needle-free Vaccination System Revenue by Type (2026-2031)
4.2.3 Global Intradermal Needle-free Vaccination System Revenue Market Share by Type (2020-2031)
4.3 Global Intradermal Needle-free Vaccination System Price by Type (2020-2031)
5 Segment by Application
5.1 Global Intradermal Needle-free Vaccination System Sales by Application (2020-2031)
5.1.1 Global Intradermal Needle-free Vaccination System Sales by Application (2020-2025)
5.1.2 Global Intradermal Needle-free Vaccination System Sales by Application (2026-2031)
5.1.3 Global Intradermal Needle-free Vaccination System Sales Market Share by Application (2020-2031)
5.2 Global Intradermal Needle-free Vaccination System Revenue by Application (2020-2031)
5.2.1 Global Intradermal Needle-free Vaccination System Revenue by Application (2020-2025)
5.2.2 Global Intradermal Needle-free Vaccination System Revenue by Application (2026-2031)
5.2.3 Global Intradermal Needle-free Vaccination System Revenue Market Share by Application (2020-2031)
5.3 Global Intradermal Needle-free Vaccination System Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Henke Sass Wolf
6.1.1 Henke Sass Wolf Company Information
6.1.2 Henke Sass Wolf Description and Business Overview
6.1.3 Henke Sass Wolf Intradermal Needle-free Vaccination System Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Henke Sass Wolf Intradermal Needle-free Vaccination System Product Portfolio
6.1.5 Henke Sass Wolf Recent Developments/Updates
6.2 HIPRA
6.2.1 HIPRA Company Information
6.2.2 HIPRA Description and Business Overview
6.2.3 HIPRA Intradermal Needle-free Vaccination System Sales, Revenue and Gross Margin (2020-2025)
6.2.4 HIPRA Intradermal Needle-free Vaccination System Product Portfolio
6.2.5 HIPRA Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Intradermal Needle-free Vaccination System Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Intradermal Needle-free Vaccination System Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Pulse NeedleFree Systems
6.4.1 Pulse NeedleFree Systems Company Information
6.4.2 Pulse NeedleFree Systems Description and Business Overview
6.4.3 Pulse NeedleFree Systems Intradermal Needle-free Vaccination System Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pulse NeedleFree Systems Intradermal Needle-free Vaccination System Product Portfolio
6.4.5 Pulse NeedleFree Systems Recent Developments/Updates
6.5 AcuShot
6.5.1 AcuShot Company Information
6.5.2 AcuShot Description and Business Overview
6.5.3 AcuShot Intradermal Needle-free Vaccination System Sales, Revenue and Gross Margin (2020-2025)
6.5.4 AcuShot Intradermal Needle-free Vaccination System Product Portfolio
6.5.5 AcuShot Recent Developments/Updates
6.6 NuGen Medical
6.6.1 NuGen Medical Company Information
6.6.2 NuGen Medical Description and Business Overview
6.6.3 NuGen Medical Intradermal Needle-free Vaccination System Sales, Revenue and Gross Margin (2020-2025)
6.6.4 NuGen Medical Intradermal Needle-free Vaccination System Product Portfolio
6.6.5 NuGen Medical Recent Developments/Updates
6.7 Shine Moon
6.7.1 Shine Moon Company Information
6.7.2 Shine Moon Description and Business Overview
6.7.3 Shine Moon Intradermal Needle-free Vaccination System Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Shine Moon Intradermal Needle-free Vaccination System Product Portfolio
6.7.5 Shine Moon Recent Developments/Updates
6.8 Jiangsu Leju Pharmaceutical Technology
6.8.1 Jiangsu Leju Pharmaceutical Technology Company Information
6.8.2 Jiangsu Leju Pharmaceutical Technology Description and Business Overview
6.8.3 Jiangsu Leju Pharmaceutical Technology Intradermal Needle-free Vaccination System Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Jiangsu Leju Pharmaceutical Technology Intradermal Needle-free Vaccination System Product Portfolio
6.8.5 Jiangsu Leju Pharmaceutical Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intradermal Needle-free Vaccination System Industry Chain Analysis
7.2 Intradermal Needle-free Vaccination System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intradermal Needle-free Vaccination System Production Mode & Process Analysis
7.4 Intradermal Needle-free Vaccination System Sales and Marketing
7.4.1 Intradermal Needle-free Vaccination System Sales Channels
7.4.2 Intradermal Needle-free Vaccination System Distributors
7.5 Intradermal Needle-free Vaccination System Customer Analysis
8 Intradermal Needle-free Vaccination System Market Dynamics
8.1 Intradermal Needle-free Vaccination System Industry Trends
8.2 Intradermal Needle-free Vaccination System Market Drivers
8.3 Intradermal Needle-free Vaccination System Market Challenges
8.4 Intradermal Needle-free Vaccination System Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Henke Sass Wolf
Hipra
Merck
Pulse NeedleFree Systems
AcuShot™Inc.
NuGen Medical
Shine Moon
Jiangsu Leju Pharmaceutical Technology
List of Tables
 Table 1. Global Intradermal Needle-free Vaccination System Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Intradermal Needle-free Vaccination System Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Intradermal Needle-free Vaccination System Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Intradermal Needle-free Vaccination System Sales (Units) of Key Manufacturers (2020-2025)
 Table 5. Global Intradermal Needle-free Vaccination System Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Intradermal Needle-free Vaccination System Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Intradermal Needle-free Vaccination System Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Intradermal Needle-free Vaccination System Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Intradermal Needle-free Vaccination System, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Intradermal Needle-free Vaccination System, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Intradermal Needle-free Vaccination System, Product Type & Application
 Table 12. Global Key Manufacturers of Intradermal Needle-free Vaccination System, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Intradermal Needle-free Vaccination System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intradermal Needle-free Vaccination System as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Intradermal Needle-free Vaccination System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Intradermal Needle-free Vaccination System Sales by Region (2020-2025) & (Units)
 Table 18. Global Intradermal Needle-free Vaccination System Sales Market Share by Region (2020-2025)
 Table 19. Global Intradermal Needle-free Vaccination System Sales by Region (2026-2031) & (Units)
 Table 20. Global Intradermal Needle-free Vaccination System Sales Market Share by Region (2026-2031)
 Table 21. Global Intradermal Needle-free Vaccination System Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Intradermal Needle-free Vaccination System Revenue Market Share by Region (2020-2025)
 Table 23. Global Intradermal Needle-free Vaccination System Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Intradermal Needle-free Vaccination System Revenue Market Share by Region (2026-2031)
 Table 25. North America Intradermal Needle-free Vaccination System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Intradermal Needle-free Vaccination System Sales by Country (2020-2025) & (Units)
 Table 27. North America Intradermal Needle-free Vaccination System Sales by Country (2026-2031) & (Units)
 Table 28. North America Intradermal Needle-free Vaccination System Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Intradermal Needle-free Vaccination System Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Intradermal Needle-free Vaccination System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Intradermal Needle-free Vaccination System Sales by Country (2020-2025) & (Units)
 Table 32. Europe Intradermal Needle-free Vaccination System Sales by Country (2026-2031) & (Units)
 Table 33. Europe Intradermal Needle-free Vaccination System Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Intradermal Needle-free Vaccination System Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Intradermal Needle-free Vaccination System Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Intradermal Needle-free Vaccination System Sales by Region (2020-2025) & (Units)
 Table 37. Asia Pacific Intradermal Needle-free Vaccination System Sales by Region (2026-2031) & (Units)
 Table 38. Asia Pacific Intradermal Needle-free Vaccination System Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Intradermal Needle-free Vaccination System Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Intradermal Needle-free Vaccination System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Intradermal Needle-free Vaccination System Sales by Country (2020-2025) & (Units)
 Table 42. Latin America Intradermal Needle-free Vaccination System Sales by Country (2026-2031) & (Units)
 Table 43. Latin America Intradermal Needle-free Vaccination System Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Intradermal Needle-free Vaccination System Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Intradermal Needle-free Vaccination System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Intradermal Needle-free Vaccination System Sales by Country (2020-2025) & (Units)
 Table 47. Middle East and Africa Intradermal Needle-free Vaccination System Sales by Country (2026-2031) & (Units)
 Table 48. Middle East and Africa Intradermal Needle-free Vaccination System Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Intradermal Needle-free Vaccination System Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Intradermal Needle-free Vaccination System Sales (Units) by Type (2020-2025)
 Table 51. Global Intradermal Needle-free Vaccination System Sales (Units) by Type (2026-2031)
 Table 52. Global Intradermal Needle-free Vaccination System Sales Market Share by Type (2020-2025)
 Table 53. Global Intradermal Needle-free Vaccination System Sales Market Share by Type (2026-2031)
 Table 54. Global Intradermal Needle-free Vaccination System Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Intradermal Needle-free Vaccination System Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Intradermal Needle-free Vaccination System Revenue Market Share by Type (2020-2025)
 Table 57. Global Intradermal Needle-free Vaccination System Revenue Market Share by Type (2026-2031)
 Table 58. Global Intradermal Needle-free Vaccination System Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Intradermal Needle-free Vaccination System Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Intradermal Needle-free Vaccination System Sales (Units) by Application (2020-2025)
 Table 61. Global Intradermal Needle-free Vaccination System Sales (Units) by Application (2026-2031)
 Table 62. Global Intradermal Needle-free Vaccination System Sales Market Share by Application (2020-2025)
 Table 63. Global Intradermal Needle-free Vaccination System Sales Market Share by Application (2026-2031)
 Table 64. Global Intradermal Needle-free Vaccination System Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Intradermal Needle-free Vaccination System Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Intradermal Needle-free Vaccination System Revenue Market Share by Application (2020-2025)
 Table 67. Global Intradermal Needle-free Vaccination System Revenue Market Share by Application (2026-2031)
 Table 68. Global Intradermal Needle-free Vaccination System Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Intradermal Needle-free Vaccination System Price (US$/Unit) by Application (2026-2031)
 Table 70. Henke Sass Wolf Company Information
 Table 71. Henke Sass Wolf Description and Business Overview
 Table 72. Henke Sass Wolf Intradermal Needle-free Vaccination System Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Henke Sass Wolf Intradermal Needle-free Vaccination System Product
 Table 74. Henke Sass Wolf Recent Developments/Updates
 Table 75. HIPRA Company Information
 Table 76. HIPRA Description and Business Overview
 Table 77. HIPRA Intradermal Needle-free Vaccination System Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. HIPRA Intradermal Needle-free Vaccination System Product
 Table 79. HIPRA Recent Developments/Updates
 Table 80. Merck Company Information
 Table 81. Merck Description and Business Overview
 Table 82. Merck Intradermal Needle-free Vaccination System Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Merck Intradermal Needle-free Vaccination System Product
 Table 84. Merck Recent Developments/Updates
 Table 85. Pulse NeedleFree Systems Company Information
 Table 86. Pulse NeedleFree Systems Description and Business Overview
 Table 87. Pulse NeedleFree Systems Intradermal Needle-free Vaccination System Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Pulse NeedleFree Systems Intradermal Needle-free Vaccination System Product
 Table 89. Pulse NeedleFree Systems Recent Developments/Updates
 Table 90. AcuShot Company Information
 Table 91. AcuShot Description and Business Overview
 Table 92. AcuShot Intradermal Needle-free Vaccination System Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. AcuShot Intradermal Needle-free Vaccination System Product
 Table 94. AcuShot Recent Developments/Updates
 Table 95. NuGen Medical Company Information
 Table 96. NuGen Medical Description and Business Overview
 Table 97. NuGen Medical Intradermal Needle-free Vaccination System Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. NuGen Medical Intradermal Needle-free Vaccination System Product
 Table 99. NuGen Medical Recent Developments/Updates
 Table 100. Shine Moon Company Information
 Table 101. Shine Moon Description and Business Overview
 Table 102. Shine Moon Intradermal Needle-free Vaccination System Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Shine Moon Intradermal Needle-free Vaccination System Product
 Table 104. Shine Moon Recent Developments/Updates
 Table 105. Jiangsu Leju Pharmaceutical Technology Company Information
 Table 106. Jiangsu Leju Pharmaceutical Technology Description and Business Overview
 Table 107. Jiangsu Leju Pharmaceutical Technology Intradermal Needle-free Vaccination System Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Jiangsu Leju Pharmaceutical Technology Intradermal Needle-free Vaccination System Product
 Table 109. Jiangsu Leju Pharmaceutical Technology Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Intradermal Needle-free Vaccination System Distributors List
 Table 113. Intradermal Needle-free Vaccination System Customers List
 Table 114. Intradermal Needle-free Vaccination System Market Trends
 Table 115. Intradermal Needle-free Vaccination System Market Drivers
 Table 116. Intradermal Needle-free Vaccination System Market Challenges
 Table 117. Intradermal Needle-free Vaccination System Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Intradermal Needle-free Vaccination System
 Figure 2. Global Intradermal Needle-free Vaccination System Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Intradermal Needle-free Vaccination System Market Share by Type: 2024 & 2031
 Figure 4. Pen-type Product Picture
 Figure 5. Gun-type Product Picture
 Figure 6. Global Intradermal Needle-free Vaccination System Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Intradermal Needle-free Vaccination System Market Share by Application: 2024 & 2031
 Figure 8. Pets and Small Animals
 Figure 9. Large Animals
 Figure 10. Global Intradermal Needle-free Vaccination System Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Intradermal Needle-free Vaccination System Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Intradermal Needle-free Vaccination System Sales (2020-2031) & (Units)
 Figure 13. Global Intradermal Needle-free Vaccination System Average Price (US$/Unit) & (2020-2031)
 Figure 14. Intradermal Needle-free Vaccination System Report Years Considered
 Figure 15. Intradermal Needle-free Vaccination System Sales Share by Manufacturers in 2024
 Figure 16. Global Intradermal Needle-free Vaccination System Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Intradermal Needle-free Vaccination System Players: Market Share by Revenue in Intradermal Needle-free Vaccination System in 2024
 Figure 18. Intradermal Needle-free Vaccination System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Intradermal Needle-free Vaccination System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Intradermal Needle-free Vaccination System Sales Market Share by Country (2020-2031)
 Figure 21. North America Intradermal Needle-free Vaccination System Revenue Market Share by Country (2020-2031)
 Figure 22. United States Intradermal Needle-free Vaccination System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Intradermal Needle-free Vaccination System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Intradermal Needle-free Vaccination System Sales Market Share by Country (2020-2031)
 Figure 25. Europe Intradermal Needle-free Vaccination System Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Intradermal Needle-free Vaccination System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Intradermal Needle-free Vaccination System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Intradermal Needle-free Vaccination System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Intradermal Needle-free Vaccination System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Intradermal Needle-free Vaccination System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Intradermal Needle-free Vaccination System Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Intradermal Needle-free Vaccination System Revenue Market Share by Region (2020-2031)
 Figure 33. China Intradermal Needle-free Vaccination System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Intradermal Needle-free Vaccination System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Intradermal Needle-free Vaccination System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Intradermal Needle-free Vaccination System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Intradermal Needle-free Vaccination System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Intradermal Needle-free Vaccination System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Intradermal Needle-free Vaccination System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Intradermal Needle-free Vaccination System Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Intradermal Needle-free Vaccination System Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Intradermal Needle-free Vaccination System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Intradermal Needle-free Vaccination System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Intradermal Needle-free Vaccination System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Colombia Intradermal Needle-free Vaccination System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Intradermal Needle-free Vaccination System Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Intradermal Needle-free Vaccination System Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Intradermal Needle-free Vaccination System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Intradermal Needle-free Vaccination System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Intradermal Needle-free Vaccination System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Intradermal Needle-free Vaccination System by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Intradermal Needle-free Vaccination System by Type (2020-2031)
 Figure 53. Global Intradermal Needle-free Vaccination System Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Intradermal Needle-free Vaccination System by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Intradermal Needle-free Vaccination System by Application (2020-2031)
 Figure 56. Global Intradermal Needle-free Vaccination System Price (US$/Unit) by Application (2020-2031)
 Figure 57. Intradermal Needle-free Vaccination System Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Intradermal Needle free Vaccination Device Market Research Report 2025
Global Veterinary Needle free Intradermal Vaccination Market Research Report 2025
Global Needle free Drug Injectors Market Research Report 2024
Medical Needle Free Syringe Market
Global Needle Free Jet Injection System Market Research Report 2025
Global Needle free Injection Systems Market Insights Forecast to 2030
Global Veterinary Needle Free Injection System Market Research Report 2025
Global Needleless Injectors Market Research Report 2024
Global Needle Free Injection Device Market Research Report 2025
Global Jet Based Needle Free Injectors Market Research Report 2024
Global Needle free Livestock Injection System Market Research Report 2024
Global Needle Free Injectors Market Research Report 2025
Global Powder based Needle free Injection System Market Insights Forecast to 2030
Global Needle Free Injection Drug Delivery System Market Research Report 2024
Global Veterinary Needle Free Injector Market Research Report 2025
Global Intradermal Injection Device Market Research Report 2025
Global Jet Needleless Injector Market Research Report 2025
Global Pneumatic Needleless Syringe Market Research Report 2024
Global Insulin Needle Free Injection Device Market Research Report 2024
Global Veterinary Needle free Injection Device Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions